Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids.
Prolonged exposure of isolated islets to supraphysiologic concentrations of palmitate decreases insulin gene expression in the presence of elevated glucose levels. This study was designed to determine whether or not this phenomenon is associated with a glucose-dependent increase in esterification of fatty acids into neutral lipids. Gene expression of sn-glycerol-3-phosphate acyltransferase (GPAT), diacylglycerol acyltransferase (DGAT), and hormone-sensitive lipase (HSL), three key enzymes of lipid metabolism, was detected in isolated rat islets. Their levels of expression were not affected after a 72-h exposure to elevated glucose and palmitate. To determine the effects of glucose on palmitate-induced neutral lipid synthesis, isolated rat islets were cultured for 72 h with trace amounts of [14C]palmitate with or without 0.5 mmol/l unlabeled palmitate, at 2.8 or 16.7 mmol/l glucose. Glucose increased incorporation of [14C]palmitate into complex lipids. Addition of exogenous palmitate directed lipid metabolism toward neutral lipid synthesis. As a result, neutral lipid mass was increased upon prolonged incubation with elevated palmitate only in the presence of high glucose. The ability of palmitate to increase neutral lipid synthesis in the presence of high glucose was concentration-dependent in HIT cells and was inversely correlated to insulin mRNA levels. 2-Bromopalmitate, an inhibitor of fatty acid mitochondrial beta-oxidation, reproduced the inhibitory effect of palmitate on insulin mRNA levels. In contrast, palmitate methyl ester, which is not metabolized, and the medium-chain fatty acid octanoate, which is readily oxidized, did not affect insulin gene expression, suggesting that fatty-acid inhibition of insulin gene expression requires activation of the esterification pathway. These results demonstrate that inhibition of insulin gene expression upon prolonged exposure of islets to palmitate is associated with a glucose-dependent increase in esterification of fatty acids into neutral lipids.
Briaud
I
I
Pacific Northwest Research Institute, University of Washington, Seattle 98122, USA.
Harmon
J S
JS
Kelpe
C L
CL
Segu
V B
VB
Poitout
V
V
D000217:Acyltransferases / Q000235:genetics; D000818:Animals; D002210:Caprylates / Q000494:pharmacology; D051048:Diacylglycerol O-Acyltransferase; D004305:Dose-Response Relationship, Drug; D004951:Esterification; D005227:Fatty Acids / Q000378:metabolism*; D015870:Gene Expression / Q000502:physiology; D005947:Glucose / Q000494:pharmacology / Q000502:physiology*; D005992:Glycerol-3-Phosphate O-Acyltransferase / Q000235:genetics; D066298:In Vitro Techniques; D007328:Insulin / Q000235:genetics; D007515:Islets of Langerhans / Q000378:metabolism*; D008055:Lipids / Q000096:biosynthesis*; D008297:Male; D009994:Osmolar Concentration; D010168:Palmitates / Q000494:pharmacology; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D011924:Rats, Zucker; D002787:Sterol Esterase / Q000235:genetics; D013997:Time Factors; D014280:Triglycerides / Q000378:metabolism
D002210:Caprylates; D005227:Fatty Acids; D007328:Insulin; D008055:Lipids; D010168:Palmitates; D012333:RNA, Messenger; D014280:Triglycerides; D000217:Acyltransferases; D005992:Glycerol-3-Phosphate O-Acyltransferase; D051048:Diacylglycerol O-Acyltransferase; D002787:Sterol Esterase; D005947:Glucose; C031492:octanoic acid